Relationship of Bone and Blood Lead Levels to Psychiatric Symptoms: The Normative Aging Study

Journal of Occupational and Environmental Medicine

Volumn 45, Issue 11, 2003, Pages 1144-1151

  Rhodes, Daniel ^a,d   Spiro III, Avron ^b   Aro, Antonio ^a,c   Hu, Howard ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BRIEF SYMPTOM INVENTORY; CLINICAL STUDY; CONTROLLED STUDY; DEPRESSION; DRUG BONE LEVEL; ENVIRONMENTAL EXPOSURE; HUMAN; LEAD BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; NORMATIVE AGING STUDY; OUTCOMES RESEARCH; PATELLA; PHOBIA; RISK FACTOR; SCORING SYSTEM; TIBIA;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALCOHOL DRINKING; BONE AND BONES; BOSTON; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; HUMANS; LEAD; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 0242582994     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000094995.23808.7b     Document Type: Article

References (34)

1. Payton M, Riggs KM, Spiro A, et al. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol. 1998;201:19-27.
2. Stewart WR, Schwartz BS, Simon D, et al. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology. 1999;52:1610-1617.
3. Hogstedt C, Hane M, Agrell A, et. al. Neuropsychological test results and symptoms among workers with well-defined long-term exposure to lead. Br J Indust Med. 1983;401:99-105.
4. Camerino D, Cassitto MG, Gilioli R. Prevalence of abnormal neurobehavioral scores in populations exposed to different industrial chemicals. Environ Res. 1993; 61:251-257.
5. Lindgren KN, Masten VL, Ford DP, et al. Relation of cumulative exposure to inorganic lead and neuropsychological test performance. Occup Environ Med. 1996;537:472-477.
6. Bleecker ML, Lindgren KN, Tiburzi MJ, et al. Curvilinear relationship between blood lead level and reaction time. J Occup Environ Med. 1997;395:426-431.
7. Lilis R, Fischbein A, Eisinger J, et al. Prevalence of lead disease among secondary lead smelter workers and biological indicators of lead exposures. Environ Res. 1977;14:255-285.
8. Baker EL, Feldman RG, White RF, et al. The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiat Scand Suppl. 1983;67:38-48.
9. Maizlish NA, Parra G, Feo O. Neurobehavioural evaluation of Venezuelan workers exposed to inorganic lead. Occup Environ Med. 1995;52:408-414.
10. Lindgren KN, Masten VL, Tiburzi MJ, et al. The factor structure of the Profile of Mood States (POMS) and its relationship to occupational lead exposure. J Occup Environ Med. 1999;411:3-10.
11. Barry PSI, Mossman DB. Lead concentrations in human tissues. Br J Indust Med. 1970;27:339-351.
12. Schroeder HA. Tipton IH. The human body burden of lead. Arch Environ Health. 1968;17:965-978.
13. Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect. 1991;91:33-37.
14. Landrigan PJ, Todd AC. Direct measurement of lead in bone. A promising biomarker. JAMA. 1994;271:239-240.
15. Bell B, Rose CL, Damen A. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev. 1972;3:4-17.
16. Derogatis LR. 1993 BSI Brief Symptom Inventory Administration, Scoring and Procedures Manual. Minneapolis, MN: National Computer Systems, Inc; 1993.
17. Burger D, Morsill P, Adams B, et al. Automated instrument for making K-x-ray fluorescence measurements in human bone. Basic Life Sci. 1990;55:287-293.
18. Hu H, Milder F, Burger DE. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposures. Arch Environ Health. 1990;45:335-341.
19. Hu H, Watanabe H, Payton M, et al. The relationship between bone lead and hemoglobin. JAMA. 1994;272:1512-1517.
20. Somervaille LJ, Chettle DR, Scott MC. In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol. 1985;20:929-943.
21. Jones KW, Schidlovsky G, Williams FH, et al. In vivo determination of tibial lead by K x-ray fluorescences with a 109 Cd source. In: Ellis KJ, Yasumura S, Morgan WD, eds. In Vivo Body Composition Studies. London: Institute of Physical Sciences in Medicine; 1987:363-373.
22. Hu H, Milder F, Burger D. X-ray fluorescence: issues surrounding the application of a new tool for measuring lead burden. Environ Res. 1989;49:295-317.
23. Gordon CL, Chettle DR, Webber CE. An improved instrument for the in vivo detection of lead in bone. Br J Indust Med. 1993;50:637-641.
24. Kim R, Aro A, Rotnitzky A, et al. K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol. 1995;40:1475-1485.
25. Hu H, Payton M, Korrick S, et al. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men, the Normative Aging Study. Am J Epidemiol. 1996;144:749-759.
26. Srole L, Langner TS, Michael ST, et al. Mental Health in the Metropolis: The Midtown Manhattan Study. New York: McGraw-Hill; 1962.
27. Kaplan HI, Saddock BJ. Synopsis of Psychiatry. Baltimore: Williams and Wilkins; 1991:133-142.
28. Minnema DJ, Greenland RD, Michaelson IA. Effect of in vitro inorganic lead on dopamine release from superfused rat striatal synaptosomes. Toxicol Appl Pharmacol. 1986;84:400-411.
29. Minnema DJ, Michaelson IA, Cooper GP. Calcium efflux and neurotransmitter release from rat hippocampal synaptosomes exposed to lead. Toxicol Appl Pharmacol. 1988;92:351-357.
30. 2+ -calmodulin and cyclic AMP in the regulation of the tyrosine hydroxylase system in rat striatal tissue slices. Biochem Pharmacol. 1985;34:2637-2643.
31. Tachikawa E, Tank AW, Yanagihara N, et al. Phosphorylation of tyrosine hydroxylase on at least three sites in rat pheochromocytoma PC12 cells treated with 56 mM K+: Determination of the sites on tyrosine hydroxylase phosphorylated by cyclic AMP-dependent and calcium/calmodulin-dependent protein kinases. Mol Pharmacol. 1986;30:476-485.
32. Bowyer JF, Nakanishi A, Houchi H, et al. Phosphorylation and activation of tyrosine hydroxylase in PC18 cells: A cell line derived from rat pheochromocytoma PC12 cells. Brain Res. 1992;591:261-270.
33. Dumas P, Gueldry D, Loireau A, et al. Effects of lead poisoning on properties of brain mitochondria in young rats. C R Soc Biol. 1985;179:175-183.
34. Kala SV, Jadhav AL. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. Neurotoxicology. 1995;16:297-308.